[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349055-105":59,"doc-detail-349055-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-critical-role-of-galnts-regulated-o-galnac-glycosylation-in-cancer-malignancy","The Critical Role of GALNTs-Regulated O-GalNAc Glycosylation in Cancer Malignancy","","Aberrant mucin-type O-glycosylation driven by the Polypeptide N-acetylgalactosaminyltransferase (GALNT) family is a hallmark of many cancers and is also linked to non-neoplastic conditions such as developmental disorders and metabolic abnormalities. Mucin-type O-GalNAc glycosylation is a prevalent, highly specific post-translational modification central to cancer progression, impacting signaling, invasion, angiogenesis, and metastasis. This review details GALNT family structure, regulation of initiation and elongation of O-GalNAc glycans, and their roles in oncology, supporting biomarker and anticancer therapeutic development.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-critical-role-of-galnts-regulated-o-galnac-glycosylation-in-cancer-malignancy/349055/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-critical-role-of-galnts-regulated-o-galnac-glycosylation-in-cancer-malignancy/349055.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is GALNTs-regulated O-GalNAc glycosylation, and why is it important in cancer?","Question",{"text":112,"@type":113},"It is mucin-type O-glycosylation mediated by GALNT enzymes. The document links it to key cancer progression processes such as signaling, invasion, angiogenesis, and metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the review characterize the research gap regarding GALNTs and O-GalNAc glycosylation in oncology?",{"text":117,"@type":113},"It states that although progress exists in understanding GALNT contributions to cancer initiation and progression, a comprehensive characterization of both the GALNT family and O-GalNAc glycosylation in cancer remains lacking.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes does the review expect from understanding GALNT-mediated glycosylation?",{"text":121,"@type":113},"The document indicates the insights may uncover underlying oncogenic mechanisms and provide new directions for anticancer therapeutics and diagnostic biomarkers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349055,1790176725,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","The FASEB Journal  \nThe Critical Role of GALNTs-Regulated O-GalNAc Glycosylation in Cancer Malignancy  \nJiahao Liu  | Sihan Wu  | Ge Zhang  | Jiehan Li  | Yuhan Yin  | Aman Uiiah  | Sanfei Peng  | Yang Fu  Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China  \nCorrespondence: Sanfei Peng ([pengsanfeit@zzu.edu.cn](pengsanfeit@zzu.edu.cn)) | Yang Fu ([fuyang@zzu.edu.cn](fuyang@zzu.edu.cn))  \nReceived: 14 December 2025 | Revised: 28 February 2026 | Accepted: 22 March 2026  \nKeywords: cancer biomarkers | cancer progression | GALNT family | O-GalNAc glycosylation  \nABSTRACT  \nAberrant mucin-type O-glycosylation, mediated by the Polypeptide N-acetylgalactosaminyltransferase (GALNT) family of enzymes, is a defining feature of many cancers and has also been strongly linked to non-neoplastic conditions, including developmental disorders and metabolic abnormalities. Mucin-type O-GalNAc glycosylation, a prevalent and highly specific form of post-translational modification, is centrally involved in key processes underlying cancer progression, such as cell signaling, invasion, angiogenesis, and metastasis. It is intricately linked to a diverse array of human diseases, with a particular association with cancer. Ongoing research endeavors to elucidate the functional mechanisms by which GALNT enzymes regulate O-GalNAc glycosylation, thereby enhancing our understanding of their pivotal roles in cancer biology. Although significant advances have been made in understanding their contributions to cancer initiation and progression, a comprehensive characterization of both the GALNT family and O-GalNAc glycosylation in oncology remains lacking. This review aims to summarize the structure of the GALNT family and its regulatory roles in the initiation and elongation of O-GalNAc glycans, providing an in-depth exploration of the functions of GALNT-mediated O-GalNAc glycosylation in cancer. Ultimately, these insights will help uncover underlying oncogenic mechanisms and may offer new potential directions for the development of anticancer therapeutics and diagnostic biomarkers.  \n1 | Introduction  \nAccording to the International Agency for Research on Cancer (IARC), there were 9.74 million global cancer deaths in 2022, accounting for approximately one-sixth of all deaths worldwide. In the same year, China reported 2.5742 million cancerrelated deaths. Cancer is widely recognized as one of the most  \nthreatening diseases globally [1] . Key challenges in contemporary cancer therapy, including late-stage diagnosis, tumor recurrence, metastasis, and drug resistance, are clinical manifestations intimately linked to dysregulated protein glycosylation. Moreover, protein glycosylation plays critical roles in diverse intra- and extracellular activities such as protein folding, cell adhesion, recognition, and host–pathogen interactions  \n\n| Abbreviations: ADCC, antibody-dependent cell-mediated cytotoxicity; AFP, alpha-fetoprotein; AXL, AXL receptor tyrosine kinase; BMP, bone morphogenetic protein; BMPR1A, bone morphogenetic protein receptor 1A; C1GALT1, core 1 β1,3-galactosyltransferase 1; CCDC88C, coiled-coil domain-containing protein 88C; CEA, carcinoembryonic antigen; CEMIP, cell migration-inducing and hyaluronan-binding protein; COPI, coat protein I; EGF, epidermal growth factor; EMT, epithelial–mesenchymal transition; ER, endoplasmic reticulum; ERK8, extracellular signal-regulated kinase 8; GALA, GALNT activation; GALNTs, polypeptide N-acetylgalactosaminyltransferases; GCNT1, glucosaminyl (N-acetyl) transferase 1; GlcNAc-1-P, glucosamine-1-phosphate; GSDME, gasdermin E; IARC, International Agency for Research on Cancer; IGFBP6, insulin-like growth factor-binding protein 6; NSCLC, non-small-cell lung cancer; PDAC, pancreatic ductaladenocarcinoma; PDGF, platelet-derived growth factor; PHB2, prohibitin-2; PRB2, basic salivary proline-rich protein 2; ProBNP, pro-brain natriuretic peptide; PSA,\u003Cbr>prostate-s","cbCaiaWA7B8gxl2D","https://ap.wps.com/l/cbCaiaWA7B8gxl2D","pdf",4396854,17,"English","# Introduction\n## Global cancer burden and clinical challenges\n## Protein glycosylation as a driver of tumorigenesis\n# Abbreviations","[{\"question\":\"What is GALNTs-regulated O-GalNAc glycosylation, and why is it important in cancer?\",\"answer\":\"It is mucin-type O-glycosylation mediated by GALNT enzymes. The document links it to key cancer progression processes such as signaling, invasion, angiogenesis, and metastasis.\"},{\"question\":\"How does the review characterize the research gap regarding GALNTs and O-GalNAc glycosylation in oncology?\",\"answer\":\"It states that although progress exists in understanding GALNT contributions to cancer initiation and progression, a comprehensive characterization of both the GALNT family and O-GalNAc glycosylation in cancer remains lacking.\"},{\"question\":\"What outcomes does the review expect from understanding GALNT-mediated glycosylation?\",\"answer\":\"The document indicates the insights may uncover underlying oncogenic mechanisms and provide new directions for anticancer therapeutics and diagnostic biomarkers.\"}]","The Critical Role of GALNTs-Regulated O-GalNAc Glycosylation in Cancer Malignancy | PDF",1790081435,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95744fc14e8688829548f74241039025.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81b881448ac2addbfc3d119f3f2429e1.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d83afce4e1fe2df48328623ac5c1c55.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d889f0fefcfd9bb3b5be4c537df9a730.webp",980,1287]